Alex Fässler is 61 years old and has dual Swiss-American citizenship. He studied chemistry at ETH Zurich, where he received his Ph.D. under the supervision of Prof. Eschenmoser. After holding a position as a research fellow at the University of California, Berkeley, he spent more than 10 years with Ciba-Geigy (now Novartis) conducting chemical research in Basel, Switzerland, Summit, USA and Macclesfield, UK. Alex Fässler joined the Bachem Group in 1998. He began as a production manager in Bubendorf, Switzerland and was subsequently assigned to the California plant, where he initially served as production manager, then plant manager and, ultimately, as Regional COO for North America. Alex Fässler returned to company headquarters in 2013 and has since managed the production plants in Switzerland, Germany and England as Regional COO for Europe.
Dr. Kuno Sommer, Chairman of the Board of Directors: "Bachem has grown rapidly in recent years and the demands this has placed on our production activities have grown considerably. We are now addressing this situation by creating the global function of Chief Operations Officer and are further strengthening our executive management in preparation for the Group's anticipated future growth. I am very pleased that we can fill this position with such a well-qualified, long-standing and highly experienced employee as Alex Fässler."
About BachemBachem is a listed, technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete the service portfolio. Headquartered in Switzerland with subsidiaries in Europe and the US, the group has a global reach with more experience and know- how than any other company in the industry. Bachem shows total commitment to quality, innovation and partnership.
Bachem Pioneering Partner for Peptides For more information: Bachem Holding AG Stephan Schindler, CFO Tel. +41 58 595 2021Fax: +41 58 595 2043
www.bachem.com ir@bachem.com
Bachem Holding AG published this content on 24 February 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 24 February 2017 05:18:09 UTC.
Original documenthttp://www.bachem.com/fileadmin/user_upload/pdf/Press_Release/2017/Press_Release_Expansion_CEC.pdf
Public permalinkhttp://www.publicnow.com/view/9B76726694DA27A2AD8B01CCD2D16C3455B9EEDA